Relay Therapeutics IPO Raises $400 Million, Exceeding Expectations

▤ Summary

Altogether that suggests a strong interest in the Relay Therapeutics IPO from institutional investors. The Relay Therapeutics IPO pricing gave it a market valuation of about $1.8 billion. Its initial focus is on "enhancing small molecule therapeutic discovery in targeted oncology. " The market for initial public offerings has come roaring back, with tech and biotechnology IPOs leading the charge. Please follow Brian Deagon on Twitter at @IBD_BDeagon for more on tech stocks, analysis and financial markets.

▦ Linked Companies